Autoimmune disease patients worry about drug shortage amid COVID-19 crisis

Last month, the U.S. Food and Drug Administration issued an Emergency Use Authorization for hydroxychloroquine sulfate and chloroquine phosphate to be used to treat certain hospitalized patients with COVID-19.